Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC14731 structure
    GC14731MTT
    CAS: 298-93-1
    纯度: >98.00% / >99.00%

    A cell-permeable and positively charged tetrazolium dye

  • GC14802 structure
    GC14802ARL 17477 dihydrochloride
    CAS: 866914-87-6

    Selective nNOS inhibitor

  • GC14823 structure
    GC14823Nitrocefin
    CAS: 41906-86-9
    纯度: >90.00%

    Nitrocefin是一种具有显色特性的头孢菌素衍生物。

  • GC14832 structure
    GC14832N-3-oxo-octanoyl-L-Homoserine lactone
    CAS: 147795-39-9
    纯度: >97.00%

    N-3-Oxo-octanoyl-L-homoserine lactone是一种属于N-酰基高丝氨酸内酯(AHL)家族的群体感应信号分子,常用于研究细菌通讯和生物膜形成。

  • GC14847 structure
    GC14847Psoralidin
    CAS: 18642-23-4
    纯度: >98.00%

    A furanocoumarin with anti-cancer activity

  • GC14851 structure
    GC14851Vidofludimus
    CAS: 717824-30-1
    纯度: >98.50%

    An immunosuppressive drug that inhibits DHODH

  • GC14864 structure
    GC14864Gardiquimod
    CAS: 1020412-43-4
    纯度: >95.00%

    Gardiquimod是一种Toll样受体7(TLR7)激动剂,能够抑制HIV1型感染人类巨噬细胞和活化T细胞。

  • GC14965 structure
    GC14965Ethyl-L-NIO (hydrochloride)
    CAS: 150403-97-7

    A modestly selective NOS inhibitor

  • GC14989 structure
    GC14989MLN120B
    CAS: 783348-36-7
    纯度: >99.50%

    An IKKβ inhibitor

  • GC15010 structure
    GC15010AMT hydrochloride
    CAS: 21463-31-0

    A potent, relatively selective inhibitor of iNOS

  • GC15031 structure
    GC15031Rapamycin (Sirolimus)
    CAS: 53123-88-9
    纯度: >98.00% / >99.50%

    Rapamycin曾经被用作抗真菌抗生素。

  • GC15048 structure
    GC15048Cyclic di-GMP
    CAS: 61093-23-0
    纯度: >98.00% / >99.50%

    Cyclic di-GMP是一种干扰素基因刺激因子(STING)激动剂。Cyclic di-GMP是一种环状二核苷酸,是细菌第二信使,能够调节不同细菌的生物膜形成、运动性和毒力。

  • GC15058 structure
    GC15058Benzydamine HCl
    CAS: 132-69-4
    纯度: >98.00%

    Benzydamine HCl是一种局部非甾体抗炎药,具有抗炎、镇痛、解热和局部麻醉活性。

  • GC15168 structure
    GC15168Urolithin A
    CAS: 1143-70-0
    纯度: >98.00%

    Urolithin A是由鞣花酸和鞣花单宁代谢产生的一种活性成分,可作为酪氨酸酶(IC 50 值为71.44±10.07µmol/L)和单胺氧化酶A(IC 50 值为29.41±9.01µmol/L)的强效抑制剂。

  • GC15251 structure
    GC15251Compstatin
    CAS: 206645-99-0

    A peptide inhibitor of complement activation

  • GC15316 structure
    GC15316NG-amino-L-Arginine (hydrochloride)
    CAS: 1031799-40-2

    Inhibitor of NOS enzymes

  • GC15320 structure
    GC15320Diacerein
    CAS: 13739-02-1
    纯度: >98.50%

    Diacerein是一种口服有效的蒽醌类化合物,对软骨和滑膜具有抗炎、抗分解代谢和促合成代谢的特性。

  • GC15355 structure
    GC153552-Trifluoromethyl-2'-methoxychalcone
    CAS: 1309371-03-6
    纯度: >98.00%

    A potent activator of Nrf2

  • GC15360 structure
    GC15360Methyl-L-NIO (hydrochloride)
    CAS: 150403-96-6

    A nitric oxide synthase inhibitor

  • GC15394 structure
    GC15394CBL0137 (hydrochloride)
    CAS: 1197397-89-9
    纯度: >98.00%

    CBL0137 (hydrochloride)是一种来自curaxins小分子家族的水溶性且代谢稳定的非遗传毒性抗癌药物,可以激活p53并抑制NF-κB,EC 50 值分别为0.37和0.47μM。

  • GC15457 structure
    GC15457Pyridoxine
    CAS: 65-23-6
    纯度: >98.00% / >99.50%

    A 4-methanol form of vitamin B 6

  • GC15548 structure
    GC15548Ellagic acid
    CAS: 476-66-4
    纯度: >99.50%

    Ellagic acid是一种天然存在的多酚二内酯,广泛存在于多种水果和坚果中,可有效抑制CK2(IC 50 =40nM)和SHP2(K i =20nM)的活性。

  • GC15550 structure
    GC15550Lacidipine
    CAS: 103890-78-4
    纯度: >99.50%

    An L-type calcium channel blocker

  • GC15586 structure
    GC15586AP1903
    CAS: 195514-63-7
    纯度: >98.00%

    AP1903是一种二价"二聚化"化合物,可与FKBP结合并诱导Fas交联。